Vanguard Group’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.1M | Buy |
1,215,644
+128,624
| +12% | +$5.41M | ﹤0.01% | 2106 |
|
|
2025
Q1 | $41.2M | Buy |
1,087,020
+23,381
| +2% | +$885K | ﹤0.01% | 2172 |
|
|
2024
Q4 | $81.9M | Buy |
1,063,639
+24,645
| +2% | +$1.9M | ﹤0.01% | 1950 |
|
|
2024
Q3 | $59.8M | Buy |
1,038,994
+61,849
| +6% | +$3.56M | ﹤0.01% | 2102 |
|
|
2024
Q2 | $40.4M | Buy |
977,145
+233,076
| +31% | +$9.64M | ﹤0.01% | 2230 |
|
|
2024
Q1 | $45.4M | Buy |
744,069
+373,131
| +101% | +$22.8M | ﹤0.01% | 2216 |
|
|
2023
Q4 | $8.26M | Sell |
370,938
-3
| -0% | -$67 | ﹤0.01% | 3059 |
|
|
2023
Q3 | $9.51M | Buy |
370,941
+213,303
| +135% | +$5.47M | ﹤0.01% | 2917 |
|
|
2023
Q2 | $2.72M | Buy |
157,638
+14,978
| +10% | +$258K | ﹤0.01% | 3565 |
|
|
2023
Q1 | $1.73M | Buy |
142,660
+23,574
| +20% | +$286K | ﹤0.01% | 3728 |
|
|
2022
Q4 | $4.25M | Sell |
119,086
-1,204
| -1% | -$43K | ﹤0.01% | 3384 |
|
|
2022
Q3 | $4.1M | Sell |
120,290
-49,130
| -29% | -$1.67M | ﹤0.01% | 3419 |
|
|
2022
Q2 | $6.23M | Sell |
169,420
-52,056
| -24% | -$1.91M | ﹤0.01% | 3251 |
|
|
2022
Q1 | $33.9M | Buy |
221,476
+1,980
| +0.9% | +$303K | ﹤0.01% | 2508 |
|
|
2021
Q4 | $64.9M | Buy |
219,496
+5,634
| +3% | +$1.66M | ﹤0.01% | 2209 |
|
|
2021
Q3 | $59.3M | Buy |
213,862
+44,012
| +26% | +$12.2M | ﹤0.01% | 2269 |
|
|
2021
Q2 | $46.6M | Buy |
169,850
+102,145
| +151% | +$28M | ﹤0.01% | 2415 |
|
|
2021
Q1 | $33.3M | Buy |
67,705
+2,164
| +3% | +$1.06M | ﹤0.01% | 2529 |
|
|
2020
Q4 | $54.1M | Buy |
+65,541
| New | +$54.1M | ﹤0.01% | 2156 |
|